Serum [bdsu]    
Potential [qlco]    
Biomarker [clna]    
Early Diagnosis [diap]    
Hepatitis C Virus-Related Hepatocellular Carcinoma [neop]    
egyptian [lang]    
patient [podg]    
circulate [ftcn]    
Deregulated [acty]    
Fibrosis, Liver [dsyn]    
Hepatocellular carcinoma [neop]    
Biomarker [clna]    
This [euka]    
studies [mnob]    
investigate [ftcn]    
Potential [qlco]    
Serum [bdsu]    
19A [gngm]    
Early [tmco]    
Diagnostic [fndg]    
Biomarker [clna]    
Hepatitis C Virus-Related Hepatocellular Carcinoma [neop]    
Change [ftcn]    
Fibrosis, Liver [dsyn]    
progress [patf]    
Not [ftcn]    
Clear [qlco]    
Serum [bdsu]    
Level [qlco]    
Fibrosis [patf]    
progress [patf]    
Hepatitis C virus [virs]    
Associated [qlco]    
Chronic liver disease [dsyn]    
If [qlco]    
Non-invasive [ftcn]    
Biomarker [clna]    
Fibrosis [patf]    
progress [patf]    
Hepatocellular carcinoma [neop]    
egyptian [lang]    
Hepatitis C virus [virs]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Non-Malignant [qlco]    
Hepatitis C virus [virs]    
Chronic liver disease [dsyn]    
patient [podg]    
Healthy Control [qlco]    
include [ftcn]    
Chronic liver disease [dsyn]    
patient [podg]    
Fibrosis [patf]    
Score [qnco]    
Serum [bdsu]    
Measurable [qlco]    
Serum [bdsu]    
Deregulated [acty]    
Hepatocellular carcinoma [neop]    
Control [grup]    
Hepatocellular carcinoma [neop]    
Chronic liver disease [dsyn]    
Late [tmco]    
Fibrosis [patf]    
subgroup [virs]    
Serum [bdsu]    
Not [ftcn]    
Different [qlco]    
Individual [popg]    
Fibrosis stage [clna]    
F2 [qnco]    
Early [tmco]    
Moderate [qlco]    
Fibrosis [patf]    
Only [qnco]    
19A [gngm]    
Fibrosis, Liver [dsyn]    
Cirrhosis [dsyn]    
Hepatocellular carcinoma [neop]    
Individual [popg]    
Discriminate [qlco]    
Hepatocellular carcinoma [neop]    
Control [grup]    
Hepatocellular carcinoma [neop]    
Chronic liver disease [dsyn]    
patient [podg]    
Receiver Operating Characteristic [qnco]    
Analysis [lbpr]    
Multivariate Analysis [qnco]    
logistic [ocac]    
reveal [qlco]    
Panel [idcn]    
Four [qnco]    
19A [gngm]    
High [qlco]    
Diagnostic Accuracy [qlco]    
Hepatocellular carcinoma [neop]    
AUC [qnco]    
Panel [idcn]    
Discriminate [qlco]    
Hepatocellular carcinoma [neop]    
Control [grup]    
AUC [qnco]    
Chronic liver disease [dsyn]    
AUC [qnco]    
AUC [qnco]    
Correlated [qlco]    
Hepatocellular carcinoma [neop]    
Group [idcn]    
19A [gngm]    
Correlated [qlco]    
Portal vein thrombosis [dsyn]    
Hepatocellular carcinoma [neop]    
Stage [ftcn]    
Score [qnco]    
Conclusion [idcn]    
Not [ftcn]    
Potential [qlco]    
Early [tmco]    
Biomarker [clna]    
Hepatocellular carcinoma [neop]    
high-risk group [popg]    
19A [gngm]    
Biomarker [clna]    
Fibrosis, Liver [dsyn]    
progress [patf]    
Cirrhosis [dsyn]    
Hepatocellular carcinoma [neop]    
Identifiable [qlco]    
Panel [idcn]    
Four [qnco]    
Serum [bdsu]    
High [qlco]    
Accuracy [qlco]    
Hepatocellular carcinoma [neop]    
Diagnosis [fndg]    
Addition [ftcn]    
studies [lbpr]    
Required [ftcn]    
To [qlco]    
confirm [qlco]    
Panel [idcn]    
Test [lbpr]    
prognostic [inpr]    
Significance [qnco]    
